Danish life science cos to enjoy 'USD bonanza' in 2023 - Nordnet

H Lundbeck A/S

28/09/2022 09:26

** Nordnet analyst Per Hansen says that although a strong
USD is a warning sign of global challenges, it's good for Danish
exporters, including life science companies, which generate a
large portion of their income in the American currency
    ** In a year USD value to DKK has increased more than 20%,
with the American dollar also strengthening against key
currencies such as GBP, JPY and CNY, he points out     
    ** The analyst names Novo Nordisk  NOVOb.CO , Coloplast
 COLOb.CO , Demant  DEMANT.CO , Lundbeck  HLUNb.CO , AMBU
 AMBUb.CO  and Novozymes  NZYMb.CO  as beneficiaries
    ** Hansen says, however, the companies will not be able to
feel the effect of the rising USD in 2022 due to currency
hedging, and expects a delayed "USD bonanza" in 2023 for the
Danish life science sector    
 (Reporting by Jacob Rasmussen)
 ((jacob.rasmussen@thomsonreuters.com))